View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Sid Rajeev
  • Sid Rajeev

The Most Undervalued Lithium Stock on Our Radar – Resuming Coverage

Lake Resources NL is resuming coverage, with its flagship Kachi lithium brine project in Catamarca province, Argentina, being a key focus. The Kachi project holds a large lithium brine resource of 10.6 Mt LCE at 218 mg/L, with a 2023 Definitive Feasibility Study (DFS) projecting an After Tax-NPV8% of US$1.7B at a lithium carbonate price of US$28k/t. Even at a lower five-year average price of US$21k/t, the project is estimated to have an AT-NPV8% of US$0.8-US$1.0B. Lake Resources stands out as t...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Sid Rajeev
  • Sid Rajeev

PEA Delivers 44% Higher NPV / Trading at a Substantial Discount - Sout...

Southern Silver Exploration Corp. (SSV) completed a new economic assessment (PEA) on its Cerro Las Minitas project in Mexico, showing strong potential profitability. The project has an after-tax net present value (NPV) of $501 million USD, but the company's stock price reflects only 12% of that value. This suggests the stock is undervalued. The company is looking at ways to advance the project and believes there's room for further resource discovery. SSV is also raising $3.5 million USD through ...

 PRESS RELEASE

Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery Syst...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs.” To hear the AudioPressRelease, please visit: To view the full editorial, please visit:  With each new study, the horizon of GLP-1’s therapeutic potential expands, painting a vibrant picture of a future where a single molecule could tackle a multitude of ...

 PRESS RELEASE

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 60+ brands within the @ (), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs,” please visi...

Lake Resources: 1 director

A director at Lake Resources maiden bought 520,369 shares at 0.137AUD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

 PRESS RELEASE

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Can Diabetes, Weight-Loss Drugs Get Even Better?” To hear the AudioPressRelease, please visit: To view the full editorial, please visit:    It shouldn’t be surprising that analysts at Markets and Research estimate the global diabetes drug market at $63.1 billion in 2021 on its way to $82.93 billion in 2027, while th...

 PRESS RELEASE

Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-De...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 60+ brands within the  @  (), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Can Diabetes, Weight-Loss Drugs Get Even Better?”,please visit:   The prest...

MarketLine Department
  • MarketLine Department

Starcore International Mines Ltd. - Mergers & Acquisitions (M&A), Part...

Summary Marketline's Starcore International Mines Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Starcore International Mines Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partners...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Sid Rajeev
  • Sid Rajeev

Southern Silver Exploration Corp. (TSXV: SSV / OTCQB: SSVFF) – Expands...

Fundamental Research Corp has issued a report entitled “Expands Resource Without Compromising on Grades” and dated April 11, 2023. The full report is now at

Sid Rajeev
  • Sid Rajeev

Southern Silver Exploration Corp. (TSXV: SSV / OTCQB: SSVFF) – Confirm...

Fundamental Research Corp has issued a report entitled “Confirms Viability of One of the Largest Undeveloped Silver Projects in the World” and dated September 7, 2022. The full report is now at

 PRESS RELEASE

Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hy...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “The Power of Science to Stop a Killer.” To hear the AudioPressRelease, please visit: To view the full editorial, please visit:  In its 2021 industry report, estimated the global anti-hypertensive drugs market at $24.17 billion in 2020 on its way to reach $27.81 billion in 2025. All told, hypertension costs the country on average ann...

 PRESS RELEASE

Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Tr...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Treat Hypertension NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 50+ trusted brands within the (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “The Power of Science to Stop a Killer,” please visit: Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More ...

Sid Rajeev
  • Sid Rajeev

Argentina Lithium & Energy Corp. (TSXV: LIT / OTC: PNXLF / FSE: OAY3) ...

Fundamental Research Corp has issued a report entitled “On The Cusp of a Potential Discovery in Argentina” and dated July 13, 2022. The full report is now at

 PRESS RELEASE

Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Del...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Nicotine Surges as Smoking Sags.” To hear the AudioPressRelease, please visit: To view the full editorial, please visit:  The fact remains that an estimated 1.1 billion people smoked cigarettes in 2019. According to stats from the World Health Organization, a stunning 780 million people said they want to quit. As a result, people look to a multitud...

 PRESS RELEASE

Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery T...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery Tech in Hot Nicotine Space NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by ("NNW"), one of 50+ trusted brands within the (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Nicotine Surges as Smoking Sags,” please visit: Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Ca...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch